tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Ownership - Who Owns Phathom Pharmaceuticals?

Compare
509 Followers

Phathom Pharmaceuticals (PHAT) Ownership Overview

11.16%16.56%10.81%8.83%52.65%
11.16% Insiders
10.81% Other Institutional Investors
8.83% ETFs
52.65% Public Companies and
Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 36.19% of the company’s stock is owned by Institutional Investors, 11.16% is owned by Insiders, and 52.65% is owned by Public Companies and Individual Investors.
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 27.36% of the company’s stock is owned by Institutional Investors, 11.16% is owned by Insiders, and 8.83% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 18, 2025
xxxxxxxxxxxxx
$14145
May 23, 2025
xxxxxxxxxxxxx
$14591
May 15, 2025
xxxxxxxxxxxxx
$24455
May 13, 2025
xxxxxxxxxxxxx
$152686

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$260618
Mar 31, 2025
xxxxxxxxxxxxx
$4713108

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,933,327Insider8.50%50,670,613
2,674,113Institution3.83%22,836,925
2,310,136Institution3.31%19,728,561
1,929,500Institution2.76%16,477,930
1,781,345Institution2.55%15,212,686
1,579,095Institution2.26%13,485,471
1,469,354Institution2.10%12,548,283
1,101,868Insider1.58%9,409,953
751,692Institution1.08%6,419,450
746,710Institution1.07%6,376,903

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,310,136Institution3.31%19,728,561
1,781,345Institution2.55%15,212,686
1,579,095Institution2.26%13,485,471
1,469,354Institution2.10%12,548,283
746,710Institution1.07%6,376,903
508,584Institution0.73%4,343,307
466,440Institution0.67%3,983,398
464,839Institution0.67%3,969,725
456,932Institution0.65%3,902,199
253,000Institution0.36%2,160,620

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,588,583Institution2.28%6,751,478
1,056,962Institution1.51%9,026,455
721,863Institution1.03%3,067,918
521,935Institution0.75%4,457,325
300,616Institution0.43%2,567,261
288,798Institution0.41%2,466,335
267,771Institution0.38%2,286,764
228,456Institution0.33%1,951,014
210,852Institution0.30%1,935,621
201,616Institution0.29%856,868

FAQ

Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 10.81% of the company's stock is held by institutional investors, 11.16% is held by insiders, and 52.65% is held by retail investors.
    What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 10.81% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
      What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 52.65% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
        Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
        James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis